Everence Capital Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,110
Closed -$132K 823
2024
Q4
$132K Sell
10,110
-1,900
-16% -$25.3K 0.01% 812
2024
Q3
$188K Sell
12,010
-400
-3% -$6.06K 0.01% 715
2024
Q2
$307 Hold
12,410
0.02% 536
2024
Q1
$344 Hold
12,410
0.02% 528
2023
Q4
$239K Hold
12,410
0.02% 645
2023
Q3
$201 Hold
12,410
0.02% 672
2023
Q2
$252K Hold
12,410
0.02% 575
2023
Q1
$181 Hold
12,410
0.01% 701
2022
Q4
$242 Hold
12,410
0.02% 619
2022
Q3
$299K Hold
12,410
0.03% 515
2022
Q2
$390K Hold
12,410
0.03% 433
2022
Q1
$546K Hold
12,410
0.04% 364
2021
Q4
$540K Hold
12,410
0.04% 392
2021
Q3
$388K Hold
12,410
0.03% 483
2021
Q2
$525K Hold
12,410
0.04% 380
2021
Q1
$466K Hold
12,410
0.04% 398
2020
Q4
$336K Buy
12,410
+390
+3% +$10K 0.03% 473
2020
Q3
$302K Sell
12,020
-10,700
-47% -$156K 0.03% 459
2020
Q2
$180K Hold
22,720
0.02% 594
2020
Q1
$208K Hold
22,720
0.03% 500
2019
Q4
$117K Hold
22,720
0.02% 660
2019
Q3
$132K Hold
22,720
0.02% 616
2019
Q2
$73K Hold
22,720
0.01% 635
2019
Q1
$93K Buy
+22,720
New +$144K 0.02% 615

Other funds holding ACH

Everence Capital Management's ACH Position: Q1 2025 in Review

Everence Capital Management sold out of Accendra Health (ACH) in Q1 2025, closing a stake of 10,110 shares — an estimated $132K sold.

Everence Capital Management first reported a position in ACH in Q1 2019 and held it in 24 quarters. The position peaked at $546K in Q1 2022. 242 funds tracked by Wall St. Rank hold ACH as of Q1 2025.

  • Everence Capital Management reported no remaining Accendra Health position as of Q1 2025 after selling out during the quarter.
  • Everence Capital Management sold 10,110 Accendra Health shares in Q1 2025, an estimated $132K.
  • Everence Capital Management first reported a position in Accendra Health in Q1 2019 and held it in 24 quarters.
  • Everence Capital Management's Accendra Health position peaked at $546K in Q1 2022.
  • 242 funds tracked by Wall St. Rank held Accendra Health as of Q1 2025.

Based on Everence Capital Management's 13F filing for Q1 2025, filed 22 Apr 2025.